COMMUNIQUÉS West-GlobeNewswire

Melinta Therapeutics Announces Appointment of Bruce L. Downey to Board of Directors
31/10/2018
NEW HAVEN, Conn., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial [...]
ChromaDex to Report Third Quarter 2018 Financial Results on Wednesday, November 7, 2018
31/10/2018
LOS ANGELES, Oct. 31, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced that it will hold a conference call on Wed., Nov. 7, 2018 at 4:30 p.m. Eastern time to discuss its financial results for the third [...]
Chembio Diagnostics Announces Proposed Public Offering of Common Stock
31/10/2018
MEDFORD, N.Y., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (NASDAQ: CEMI) (“Chembio”), a provider of point-of-care diagnostic tests for infectious diseases, announced today that it has commenced an [...]
Conformis Reports Third Quarter 2018 Financial Results and Updates Fiscal Year 2018 Guidance
31/10/2018
BILLERICA, Mass., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell [...]
OrthoPediatrics Corp. Reports Third Quarter 2018 Financial Results
31/10/2018
Third Quarter 2018 Revenue Increased 27.8% Year-over-Year to $15.8 Million Full Year 2018 Revenue Growth Guidance Increased to a Range of 25.0% to 25.5% WARSAW, Ind., Oct. 31, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics [...]
TRACON to Report Third Quarter 2018 Company Highlights and Financial Results on November 7, 2018
31/10/2018
SAN DIEGO, Oct. 31, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer [...]
Dermira to Report Third Quarter 2018 Results and Host Conference Call on Wednesday, November 7, 2018
31/10/2018
MENLO PARK, Calif., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]
Editas Medicine to Host Conference Call Discussing Third Quarter 2018 Corporate Update and Results
31/10/2018
CAMBRIDGE, Mass., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that it will host a conference call and webcast on Wednesday, November 7, 2018, [...]
Sientra to Participate in Upcoming Investor Conferences
31/10/2018
SANTA BARBARA, Calif., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN), a medical aesthetics company, announced today that members of management are scheduled to participate in three upcoming investor [...]
Cerecor Announces Submission of Three Orphan Drug Designation Requests for Substrate Replacement Therapies to treat Congenital Disorders of Glycosylation
31/10/2018
BALTIMORE, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare and orphan diseases in [...]
CV Sciences, Inc. to Host Third Quarter 2018 Financial Results Conference Call on Wednesday, November 7, 2018
31/10/2018
LAS VEGAS, Oct. 31, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI), preeminent supplier and manufacturer of industry leading hemp extract brand, PlusCBD Oil™ , announced that it is scheduled to host a [...]
Soricimed Publishes New Research Validating TRPV6 as a Therapeutic Target for Ovarian Cancer
31/10/2018
MONCTON, New Brunswick, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Soricimed Biopharma Inc. ("Soricimed"), a clinical-stage pharmaceutical company discovering and developing targeted cancer therapeutics, is pleased to announce [...]
Ira Duarte Promoted to Chief Financial Officer of Veloxis Pharmaceuticals A/S
31/10/2018
Company Release no. 18/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 31 October 2018 Ira Duarte Promoted to Chief Financial Officer of Veloxis Pharmaceuticals A/S Veloxis Pharmaceuticals A/S (NASDAQ: VELO) today [...]
Tabula Rasa HealthCare to Participate in Upcoming Investor Conference
31/10/2018
MOORESTOWN, N.J., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, today announced that Chairman and CEO, [...]
Eurobio Scientific : LEVEE DE FONDS OBLIGATAIRE D'UN MONTANT DE 2,5 M€ AVEC VATEL DIRECT
31/10/2018
LEVEE DE FONDS OBLIGATAIRE D'UN MONTANT DE 2,5 M€ AVEC VATEL DIRECT Eurobio Scientific et Vatel Direct clôturent avec succès une nouvelle levée de fonds obligataire de 2,5 M€ pour financer de potentielles acquisitions [...]
Sandoz receives US FDA approval for biosimilar Hyrimoz(TM) (adalimumab-adaz)
31/10/2018
Biosimilar Hyrimoz TM (adalimumab-adaz) approved for all indications of reference medicine not protected by orphan exclusivity ** Biosimilars are critical to sustaining US healthcare system, providing broader access to [...]
Change to Executive Management: Anders Hedegaard leaves as CEO of GN Hearing
31/10/2018
Anders Hedegaard has decided to resign as CEO of GN Hearing. Marcus Desimoni will act as interim CEO of GN Hearing, in parallel with his role as CFO of GN Store Nord and GN Hearing, until a new CEO of GN Hearing is [...]
Orion Biotechnology Completes Scientific Advice Meeting with MHRA
31/10/2018
OTTAWA, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a developer of novel medical treatments, announced today the completion of a scientific advice meeting with the Medicines and Healthcare [...]
NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology
31/10/2018
WALTHAM, Mass., Oct. 31, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,112,040 titled “Transcutaneous electrical nerve [...]

Pages